Abstract
dc:descriptionThe effectiveness of immunotherapies administered in myeloid malignancies such as myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML) remains controversial. Clinical data have demonstrated increased toxicity and limited benefit in MDS and CMML, while selected patients with AML have shown better responses. These discrepancies are potentially attributed to the heterogeneity of the bone marrow immune microenvironment. Previous studies have reported reduced diversity in T-cell receptor (TCR) repertoires among patients with MDS and AML compared to healthy donors, a factor that may influence immunotherapy response.This study investigates the diversity and clonality of T-cell receptor repertoires in CD4+ and CD8+ T cells from patients with AML, MDS, and CMML undergoing treatment with azacitidine (AZA). Using MiXCR and VDJtools, we observed that patients with AML exhibit significantly higher TCR diversity compared to those with MDS or CMML, suggesting distinct mechanisms of immune evasion. Treatment with AZA increased TCR diversity in MDS but led to its reduction in CMML, indicating divergent immune responses. These findings highlight the potential of TCR-based biomarkers to predict treatment outcomes and emphasize the need for personalized immunotherapeutic approaches tailored to the unique immune landscapes of these hematologic malignancies. Overall, the study underscores the importance of the TCR repertoire as a tool for understanding immunological differences between MDS, CMML, and AML, as well as the impact of AZA treatment on these immune landscapes. The results support the development of diagnostic and therapeutic strategies based on the immune status of individual patients, promoting the implementation of precision medicine in hematologic cancers.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsiki, Kyriaki
- Κατσίκη, Κυριακή
Subjects
dc:subject × 28- Αζακιτιδίνη (AZA)
- Αιματολογική κακοήθεια
- Μυελοδυσπλαστικά σύνδρομα (MDS)
- Οξεία μυελογενής λευχαιμία (AML)
- Ποικιλομορφία υποδοχέων Τ κυττάρων (TCR)
- Χρόνια μυελομονοκυτταρική λευχαιμία (CMML)
- Azacitidine (AZA)
- Hematologic Malignancy
- Biomarkers
- Myelodysplastic Syndromes (MDS)
- Acute Myeloid Leukemia (AML)
- T-Cell Receptor Diversity (TCR)
- Chronic Myelomonocytic Leukemia (CMML)
- Βιολογία
- Φυσικές Επιστήμες
- Βιοχημεία και Μοριακή βιολογία
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ανοσολογία
- Μοριακή ιατρική
- Biological Sciences
- Natural Sciences
- Biochemistry and Molecular Biology
- Biology
- Basic Medicine
- Medical and Health Sciences
- Immunology
- Molecular Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60290